Long-term safety and effectiveness of roflumilast cream 0.3% in adults with chronic plaque psoriasis: A 52-week, phase 2, open-label trial

Bibliographic Details
Title: Long-term safety and effectiveness of roflumilast cream 0.3% in adults with chronic plaque psoriasis: A 52-week, phase 2, open-label trial
Authors: Stein Gold, Linda, Adam, David N., Albrecht, Lorne, Alonso-Llamazares, Javier, Ferris, Laura K., Gooderham, Melinda J., Hong, H. Chih-ho, Kempers, Steven E., Kircik, Leon H., Lebwohl, Mark, Loo, Wei Jing, Nahm, Walter K., Papp, Kim A., Stewart, Daniel, Toth, Darryl P., Zirwas, Matthew, Krupa, David, Snyder, Scott, Burnett, Patrick, Higham, Robert, Berk, David R.
Source: In Journal of the American Academy of Dermatology August 2024 91(2):273-280
Database: ScienceDirect
More Details
ISSN:01909622
DOI:10.1016/j.jaad.2024.03.030
Published in:Journal of the American Academy of Dermatology
Language:English